Kidney problems: Semaglutide may cause acute kidney injury or worsening kidney disease, particularly in patients with chronic kidney disease or end-stage kidney disease
If you have questions or doubts, be sure to consult a doctor
GLP-1 Receptor Response: When semaglutide is injected into the body, it activates GLP-1 receptors in releasing insulin (which stops glucagon production) helping manage healthy blood sugar levels and weight
His personalized approach combines weight loss medications, nutrition coaching, and metabolic health strategies to help patients achieve sustainable, long-term wellness
If you carry variants linked to rapid rebound, your provider may recommend continuous therapy, higher maintenance doses, or dual-compound therapy (GLP-Squared) for stronger appetite suppression